Stay updated on Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial

Sign up to get notified when there's something new on the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was applied and an older funding notice was removed; these are maintenance updates that do not change trial details on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:34:42.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a government funding status notice and a new revision label (v3.4.1); these changes do not alter study details, results, or enrollment information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:39:53.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a glossary display option and updated metadata labels to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with a new revision tag 'Revision: v3.4.0', replacing the previous QC and data labels. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:25:59.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4. No substantive content or functionality changes are observed.
    Difference
    0.1%
    Check dated 2026-01-14T02:45:24.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a Locations section including Missouri and updated the page revision from v3.3.2 to v3.3.3; the Missouri Locations heading was removed along with the HHS Vulnerability Disclosure item.
    Difference
    0.2%
    Check dated 2025-12-23T17:15:27.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Footer revision updated from Revision: v3.2.0 to Revision: v3.3.2 on the page; no study data or content changes observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:02:53.000Z thumbnail image

Stay in the know with updates to Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Optune in Melanoma Brain Mets + Immune Checkpoint Inhibitors Clinical Trial page.